(E)-3-(1-(2-HYDROXY-5-NITROPHENYLAMINO)ETHYLIDENE)-6-METHYL-2HPYRAN-2,4(3H)-DIONE


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	CHOGOHAPAPEULY-MDWZMJQESA-N
Smiles	C\C(=C\1/C(=O)OC(=CC1=O)C)\Nc2cc(ccc2O)[N+](=O)[O-]
InChI	InChI=1S/C14H12N2O6/c1-7-5-12(18)13(14(19)22-7)8(2)15-10-6-9(16(20)21)3-4-11(10)17/h3-6,15,17H,1-2H3/b13-8+

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C14H12N2O6
Molecular Weight	304.25
AlogP	1.7
Hydrogen Bond Acceptor	7.0
Hydrogen Bond Donor	2.0
Number of Rotational Bond	3.0
Polar Surface Area	121.44
Molecular species	ACID
Aromatic Rings	1.0
Heavy Atoms	22.0

Assay Description	Organism	Bioactivity
Phytotoxicity against Urochloa decumbens pregerminated seeds assessed as inhibition of aerial parts development at 5x10'-4 mol/l at 28 degC after 24 to 48 hr by sand based radicle elongation assay	Urochloa decumbens	15.0 %
Phytotoxicity against Urochloa decumbens pregerminated seeds assessed as inhibition of root biomass development at 5x10'-4 mol/l at 28 degC after 24 to 48 hr by sand based radicle elongation assay	Urochloa decumbens	15.0 %
Phytotoxicity against Ipomoea grandifolia pre-germinated seeds assessed as inhibition of aerial parts development at 5x10'-4 mol/l at 28 degC after 24 to 48 hr by sand based radicle elongation assay	Ipomoea grandifolia	76.0 %
Phytotoxicity against Ipomoea grandifolia pre-germinated seeds assessed as inhibition of root biomass development at 5x10'-4 mol/l at 28 degC after 24 to 48 hr by sand based radicle elongation assay	Ipomoea grandifolia	81.0 %
Phytotoxicity against Urochloa decumbens seeds assessed as inhibition of aerial parts development at 5x10'-5 mol/kg measured at 21 days after seed sowing by green house trials	Urochloa decumbens	15.0 %
Phytotoxicity against Urochloa decumbens seeds assessed as inhibition of root biomass development at 5x10'-5 mol/kg measured at 21 days after seed sowing by green house trials	Urochloa decumbens	15.3 %
Phytotoxicity against Ipomoea grandifolia seeds assessed as inhibition of aerial parts development at 5x10'-5 mol/kg measured at 21 days after seed sowing by green house trials	Ipomoea grandifolia	78.9 %
Phytotoxicity against Ipomoea grandifolia seeds assessed as inhibition of root biomass development at 5x10'-5 mol/kg measured at 21 days after seed sowing by green house trials	Ipomoea grandifolia	79.9 %
Phytotoxic activity against Cucumis sativus (cucumber)seeds assessed as inhibition of radicle growth at 10'-3 mol/l at 25 degC after 72 hr by filter-paper based radicle elongation assay	Cucumis sativus	58.1 %
Phytotoxic activity against Cucumis sativus (cucumber)seeds assessed as inhibition of radicle growth at 10'-4 mol/l at 25 degC after 72 hr by filter-paper based radicle elongation assay	Cucumis sativus	-12.4 %
Phytotoxic activity against Sorghum bicolor seeds assessed as inhibition of radicle growth at 10'-3 mol/l at 25 degC after 72 hr by filter-paper based radicle elongation assay	Sorghum bicolor	55.6 %
Phytotoxic activity against Sorghum bicolor seeds assessed as inhibition of radicle growth at 10'-4 mol/l at 25 degC after 72 hr by filter-paper based radicle elongation assay	Sorghum bicolor	3.9 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2229200
PubChem	25223957

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).